BAY3389934

DRUG2 trials

Sponsors

Bayer

Conditions

CoagulopathyDrug-drug InteractionSepsis

Phase 1

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

RecruitingNCT06854640

BayerCoagulopathy, Sepsis

Start: 2025-03-12End: 2027-01-17Target: 36Updated: 2026-08-20

A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

RecruitingNCT07652723

BayerDrug-drug Interaction

Start: 2026-05-29End: 2026-11-11Target: 16Updated: 2026-08-26